AI Research Summary
Before Human ReviewAbstract-based · Full paper not reviewed · Not an official association position
This is a summary based on the abstract, and the full text was not reviewed. The study compared how well stakeholder values for high-risk cardiovascular AI-CDSS align with the EU AI Act. The authors argue that some values are not sufficiently captured by the AI Act requirements, and in particular human oversight, transparency, and fairness are only partially reflected. They suggest that contractual strategies may serve as complementary grounds for value alignment and the fulfillment of due diligence.
Key Points from the Abstract
- The AI Act captured only part of stakeholder values.
- Human oversight, transparency, and fairness were only partially supported.
- Contractual strategies were proposed as a complementary means.
Relevance to AI Law and Policy
It is useful for regulatory and governance review by showing the value fit of the EU AI Act and medical AI-CDSS, as well as the possibility of contractual supplementation.
Limitations to Consider
- Based on the abstract only; the full text was not reviewed.
- The specific empirical design and data scope cannot be determined from the abstract alone.
- The legal effect of the proposal cannot be confirmed from the abstract alone.
Please compare with the original text before citing or using it in your assessment.
Abstract Preview
Abstract The European Union Artificial Intelligence (AI) Act was adopted in 2024 to protect public…Read more in the abstract and original text Research Topic
Original text and source
Conformity Between Values and EU Legal Requirements Regarding an AI Clinical Decision Support System (AI-CDSS) for Improved Cardiovascular Risk Management (DECIDE)
The Korean title on this page was translated by AI.- Journal or publication
- Journal of Law, Medicine & Ethics
- Original publisher
- Cambridge University Press (CUP)
- Database
- Crossref